Company Active LTD

Company profile

Epigem Limited

UK company 02954592, incorporated on 1 August 1994.

Epigem Leaders in Microfluidics and Customisable Fine-Line Microcircuitry

Epigem Limited is a UK company with status Active founded in 1994 based in North East England.

Company number
02954592
Incorporated
1 Aug 1994
Companies House status
Active

Company identity

Founded / incorporated
1 August 1994

Company number 02954592

Verify at Companies House
Legal name
EPIGEM LIMITED
Company type
Private Limited Company
Region
North East England
Registered address
MALMO COURT
KIRKLEATHAM BUSINESS PARK
REDCAR
TS10 5SQ
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 1
1
Company Active LTD
Epigem Limited
CRN 02954592
2
Direct and ultimate controller Active LTD
Jeantec Ltd
CRN 07000488

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
8

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

15 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

14 Aug
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUzODc0MTI5MGFkaXF6a2N4

Published 14 Aug 2026 11:17

01 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

01 Aug
1994

Incorporated

Inception

Company registered at Companies House

Public funding

13 awards
First funded
2005
Funded years
2005, 2007, 2009, 2010, 2013, 2014, 2015, 2017, 2019
Age at first award
10 years

Projects

2019 Collaborative R&D Lead participant

An integrated microfluidic – single cell Raman technology for rapid diagnosis of pathogens and their antibiotic resistance

1 Jan 2019 to 31 Aug 2022

Awarded
£302,082
Total cost £431,545

The global spread of anti-microbial resistance (AMR) is one of the biggest threats to human health. A rapid diagnosis of AMR within 1-3 hours to infectious disease will not only reduce uncertainty in diagnosis, saving millions of lives (e.g. those lost through sepsis), but also enable an effective help to clinical doctors making the best use of antibiotic...

2017 Knowledge Transfer Partnership

University of Northumbria at Newcastle and Epigem Limited

1 Jan 2017 to 31 Dec 2018

Awarded
Unknown

To develop 'IMPEL'- Innovative microsystem for medical practioner, point-of- care, sub 20 minute diagnosis of infectious disease, using automated serological and PCR analysis, integrating state of the art design, surface acoustics, microfluidics, microelectronic, Internet of Things, process and data control.

2015 Vouchers Lead participant

epigem

1 May 2015 to 31 Oct 2015

Awarded
£5,000
Total cost £5,000

Epigem Ltd is a polymer micro engineering company specialising in the development and manufacture of devices based on the company’s three technology platforms: microfluidics, electrodes, and optics.The company is currently looking to introduce an electrode based technology into the NHS for the treatment of heart arrhythmia.

2014 GRD Proof of Concept Lead participant

Force sensing resistive touch sensor

1 Jul 2014 to 31 Mar 2016

Awarded
£99,735
Total cost £166,226

Force sensing touch (FST) sensors provide extra functionality compared to existing touch sensors based on capacitive sensing. They enable a new type of gesturing – the ability for electronic devices to recognize the location and amount of force or pressure of a touch point. This can be used in track-pads, keyboards, touch screens, game controllers and the...

2013 Collaborative R&D Lead participant

"MIMIC" - Multifunctional Integrated Microsystem for rapid point-of-care TB IdentifiCation

1 Oct 2013 to 30 Jun 2017

Awarded
£530,760
Total cost £884,600

One third of the world’s population is infected with TB and there are nine million new cases of active TB every year. While delays in diagnosing the disease result in a potential infection spreading, the diagnosis of TB on clinical grounds alone is difficult as patients often have only non-specific symptoms. Current diagnostic tests are facing major limit...

2013 Collaborative R&D Lead participant

'MilkED': Development of a point of need diagnostic test for infectious disease in milk in dairies

1 Oct 2013 to 30 Jun 2017

Awarded
£404,999
Total cost £674,998

The 'MilkED' project is aimed at developing a device to rapidly detect pathogens in milk, within the milk parlour or milk tank. It is focused on Mycobacterium avium subspecies paratuberculosis (MAP), a pathogen infecting cattle and other ruminants, causing chronic diarrhoea, emaciation, and often leading to death. In addition to detrimental effects on the...

2013 GRD Proof of Market Lead participant

Epimesh proof of market

1 Apr 2013 to 30 Sep 2013

Awarded
£25,000
Total cost £48,380

Epigem has developed a new type of transparent conducting film which has higher optical transmission (>85%) and lower electrical surface resistance (~1 Ohm/square) compared to existing materials, whilst having no colour. Epigem hopes to make and sell a range of these new films under the brand name "Epimesh". More details of the product are given in Append...

2010 Collaborative R&D

FlexIC - Printed Logic Supply Chain

1 Oct 2010 to 31 Mar 2013

Awarded
£144,000
Total cost £300,432

The transistor is the basic building block for logic and has been key to the success of microelectronics from highly demanding aerospace applications to commoditised consumer electronics. Printed logic, analogous to the silicon integrated chip, is necessary for plastic electronics to realise its forecast huge potential. Today logic accounts for just £7M (...

2010 Feasibility Studies Lead participant

Integrated surface acoustic wave functions for DIIA (iSAW)

1 Sep 2010 to 30 Nov 2011

Awarded
£60,000
Total cost £80,000

Awaiting Public Summary

2009 Collaborative R&D

Willet

1 Jan 2009 to 31 Dec 2011

Awarded
£428,510
Total cost £714,184

‘Morris’ is a 3 year program to develop large area (~1m diagonal and up), reflective colour display surfaces, made by printed/plastic electronic processes, for use in applications such as command/control rooms, electronic whiteboards, posters and signage, and architectural/ interior design (electronic wallpaper). The partners are Hewlett-Packard, Timsons ...

2007 Collaborative R&D Lead participant

Novel Transparent Conducting Films and Their Use As An Alternative to ITO

1 Oct 2007 to 31 Dec 2009

Awarded
£158,656
Total cost £368,968

Awaiting Public Summary

2005 Collaborative R&D

Integrated functional Substrates for plastic display systems and polymer electronics

1 Mar 2005 to 30 Nov 2007

Awarded
£273,000
Total cost £682,054

Awaiting Public Summary

Product types

Collaborative R&D Feasibility Studies GRD Proof of Concept GRD Proof of Market Knowledge Transfer Partnership Vouchers